160 related articles for article (PubMed ID: 33392399)
1. Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an
Stefanowicz S; Wlodarczyk W; Frosch S; Zschaeck S; Troost EGC
Clin Transl Radiat Oncol; 2021 Mar; 27():24-31. PubMed ID: 33392399
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer.
Stefanowicz S; Stützer K; Zschaeck S; Jakobi A; Troost EGC
Radiat Oncol; 2018 Nov; 13(1):228. PubMed ID: 30466468
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
[TBL] [Abstract][Full Text] [Related]
4. Investigate the Dosimetric and Potential Clinical Benefits Utilizing Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost Technique for Locally Advanced Pancreatic Cancer: A Comparison Between Photon and Proton Beam Therapy.
Liu P; Gao XS; Wang Z; Li X; Xi C; Jia C; Xie M; Lyu F; Ding X
Front Oncol; 2021; 11():747532. PubMed ID: 34631584
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
6. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
Front Oncol; 2019; 9():1456. PubMed ID: 31998635
[No Abstract] [Full Text] [Related]
7. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation - an intraindividual comparison.
Marnitz S; Wlodarczyk W; Neumann O; Koehler C; Weihrauch M; Budach V; Cozzi L
Radiat Oncol; 2015 Apr; 10():91. PubMed ID: 25896675
[TBL] [Abstract][Full Text] [Related]
8. Short-course PET based simultaneous integrated boost for locally advanced cervical cancer.
Arnesen MR; Rekstad BL; Stokke C; Bruheim K; Løndalen AM; Hellebust TP; Malinen E
Radiat Oncol; 2016 Mar; 11():39. PubMed ID: 26968827
[TBL] [Abstract][Full Text] [Related]
9. Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans.
Xia F; Zhou L; Yang X; Chu L; Zhang X; Chu J; Hu W; Zhu Z
J Thorac Dis; 2017 Dec; 9(12):5194-5202. PubMed ID: 29312726
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer.
Oonsiri S; Kitpanit S; Kannarunimit D; Chakkabat C; Lertbutsayanukul C; Prayongrat A
Phys Imaging Radiat Oncol; 2022 Apr; 22():51-56. PubMed ID: 35514527
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Comparison of Intensity-Modulated Proton Therapy and Volumetric-Modulated Arc Therapy in Anal Cancer Patients and the Ability to Spare Bone Marrow.
Meier T; Mascia A; Wolf E; Kharofa J
Int J Part Ther; 2017; 4(2):11-17. PubMed ID: 31773004
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric Comparison of Helical Tomotherapy, Volumetric-Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Angiosarcoma of the Scalp.
Mizuno T; Tomita N; Takaoka T; Tomida M; Fukuma H; Tsuchiya T; Shibamoto Y
Technol Cancer Res Treat; 2021; 20():1533033820985866. PubMed ID: 33517860
[TBL] [Abstract][Full Text] [Related]
13.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
15. Potential of intensity-modulated radiotherapy to escalate doses to head-and-neck cancers: what is the maximal dose?
Zhou J; Fei D; Wu Q
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):673-82. PubMed ID: 14529771
[TBL] [Abstract][Full Text] [Related]
16. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy.
Teng F; Meng L; Zhu F; Ren G
J Gastrointest Oncol; 2021 Apr; 12(2):496-506. PubMed ID: 34012643
[TBL] [Abstract][Full Text] [Related]
18. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
19. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
20. Sparing Organs at Risk with Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Locally Advanced Non-Small Cell Lung Cancer: An Automatic Treatment Planning Study.
Wang D; Chen J; Zhang X; Zhang T; Wang L; Feng Q; Zhou Z; Dai J; Bi N
Cancer Manag Res; 2020; 12():9643-9653. PubMed ID: 33116824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
